List of bibliographic references
Number of relevant bibliographic references: 43.
[0-20] [
0 - 20][
0 - 43][
20-40]
Ident. | Authors (with country if any) | Title |
---|
000016 (2009) |
Mao Mao An [République populaire de Chine] ; Zui Zou [République populaire de Chine] ; Hui Shen [République populaire de Chine] ; Jun Dong Zhang [République populaire de Chine] ; Yong Bing Cao [République populaire de Chine] ; Yuan Ying Jiang [République populaire de Chine] | The addition of tocilizumab to DMARD therapy for rheumatoid arthritis: a meta-analysis of randomized controlled trials |
000026 (2016) |
Young Ho Lee [Corée du Sud] ; Sang-Cheol Bae [Corée du Sud] | Comparative efficacy and safety of tocilizumab, rituximab, abatacept and tofacitinib in patients with active rheumatoid arthritis that inadequately responds to tumor necrosis factor inhibitors: a Bayesian network meta‐analysis of randomized controlled trials |
000087 (2011) |
K. Krüger [Allemagne] ; B. Hellmich [Allemagne] ; A. Rubbert-Roth [Allemagne] ; U. Müller-Ladner [Allemagne] ; A. Kielhorn [Allemagne] | Ist der Vergleich verschiedener Studien zur Wirksamkeit von Biologika bei Patienten mit rheumatoider Arthritis möglich? |
000088 (2011) |
Emily Beth Devine [États-Unis] ; Rafael Alfonso-Cristancho [États-Unis] ; Sean D. Sullivan [États-Unis] | Effectiveness of Biologic Therapies for Rheumatoid Arthritis: An Indirect Comparisons Approach |
000105 (2012) |
M. Gallego-Galisteo ; A. Villa-Rubio ; E. Alegre-Del Rey [Espagne] ; E. Márquez-Fernández ; J. J. Ramos-Báez | Indirect comparison of biological treatments in refractory rheumatoid arthritis |
000115 (2014) |
Selda Celik [États-Unis] ; Yusuf Yazici [États-Unis] ; Hasan Yazici [Turquie] | Are sample sizes of randomized clinical trials in rheumatoid arthritis too large? |
000130 (2007) |
Gerald Gartlehner [Autriche, États-Unis] ; Richard A. Hansen [États-Unis] ; Beth L. Jonas [États-Unis] ; Patricia Thieda [États-Unis] ; Kathleen N. Lohr [États-Unis] | Biologics for the treatment of juvenile idiopathic arthritis: a systematic review and critical analysis of the evidence |
000161 (2013) |
I. Kötter [Allemagne] ; J. C. Henes [Allemagne] | Etablierte Medikamente |
000166 (2013) |
J. Wollenhaupt [Allemagne] ; K. Albrecht [Allemagne] ; K. Krüger [Allemagne] ; U. Müller-Ladner [Allemagne] | The new 2012 German recommendations for treating rheumatoid arthritis |
000201 (2014) |
Kosmas Kretsos [Royaume-Uni] ; Georg Golor [Allemagne] ; Astrid Jullion [Belgique] ; Matthew Hickling [Royaume-Uni] ; Suzanne Mccabe [Belgique] ; Stevan Shaw [Royaume-Uni] ; Joby Jose [Royaume-Uni] ; Ruth Oliver [Royaume-Uni] | Safety and pharmacokinetics of olokizumab, an anti‐IL‐6 monoclonal antibody, administered to healthy male volunteers: A randomized phase I study |
000206 (2012) |
K. Krüger [Allemagne] ; J. Sieper [Allemagne] | Off-Label-Therapie bei rheumatoider Arthritis und Spondyloarthritiden |
000315 (2011) |
Kjell Tullus [Royaume-Uni] | New developments in the treatment of systemic lupus erythematosus |
000461 (2011) |
Alberto Migliore [Italie, Espagne] ; Emanuele Bizzi [Italie] ; Serena Broccoli [Italie] ; Bruno Laganà [Italie] | Indirect comparison of etanercept, infliximab, and adalimumab for psoriatic arthritis: mixed treatment comparison using placebo as common comparator |
000590 (2013) |
Benjamin Terrier [France] ; Luc Mouthon [France] | Lupus érythémateux systémique |
000614 (2013) |
G. R. Burmester [Allemagne] ; A. Rubbert-Roth [Allemagne] ; A. Cantagrel [France] ; S. Hall [Australie] ; P. Leszczynski [Pologne] ; D. Feldman [Brésil] ; M. J. Rangaraj ; G. Roane ; C. Ludivico [États-Unis] ; E. Mysler [Argentine] ; L. Rowell [Royaume-Uni] ; I. Vranic [Royaume-Uni] | SAT0105 Summacta: A Randomized, Double-Blind, Parallel Group Study of the Safety and Efficacy Of Tocilizumab SC Versus Tocilizumab IV, in Combination with Traditional Dmards in Patients With Moderate to Severe Ra |
000640 (2013) |
B. Combe [France] ; M. Dougados [France] ; I. Logeart ; C. Lukas [France] ; X. Mariette [France] ; X. Puechal ; A. Saraux ; T. Schaeverbeke [France] | AB0516 An open-label randomized controlled study to evaluate the efficacy of etanercept (ETN) versus rituximab (RTX), in patients with active rheumatoid arthritis previously treated with RTX and TNF blockers |
000725 (2013) |
J. A. Singh [États-Unis] ; G. Wells [Canada] ; R. Christensen [Danemark] ; E. Ghogomu [Canada] ; J. Macdonald [Canada] ; L. Maxwell [Canada] ; S. Tarp [Danemark] ; R. Buchbinder [Australie] ; P. Tugwell [Canada] | OP0071 Risk of Cancer, Serious Lung Infections and Death with Biologics: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials (RCTS) |
000793 (2011) |
Sheila L. Arvikar [États-Unis] ; Mark C. Fisher [États-Unis] | Inflammatory bowel disease associated arthropathy |
000804 (2013) |
T. Takeuchi [Japon] ; Y. Kaneko [Japon] ; T. Atsumi ; Y. Tanaka ; M. Inoh ; H. Kobayashi [Japon] ; K. Amano ; M. Miyata ; Y. Murakawa ; T. Fujii ; A. Kawakami ; H. Yamanaka ; K. Yamamoto ; N. Miyasaka [Japon] ; T. Mimori | OP0040 Adding Tocilizumab or Switching to Tocilizumab Monotherapy in RA Patients with Inadequate Response to Methotrexate: 24-Week Results from a Randomized Controlled Study (Surprise Study) |
000908 (2013) |
S. Celik [États-Unis] ; Y. Yazici [États-Unis] | SAT0480 How many patients do we really need to enroll in randomized clinical trials of biologic agents for the treatment of rheumatoid arthritis? An analysis of published trials |
000967 (2013) |
V. Bruzzese [Italie] ; R. Lorenzetti [Italie] ; A. Zullo [Italie] ; C. Hassan [Italie] ; S. M. Campo [Italie] | OP0070 Anti-TNF Therapy and Tuberculosis Risk in Rheumatic Diseases, Psoriasis, and IBD: A Pooled-Data Analysis of Randomized Controlled Trials |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Istex/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i -k "randomized"
HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i \
-Sk "randomized" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= TocilizumabV1
|flux= Istex
|étape= Curation
|type= indexItem
|index= AbsEn.i
|clé= randomized
}}
| This area was generated with Dilib version V0.6.34. Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021 | |